Clin2
NCT06344819Possibly a fitRecruiting

Acupuncture for People at High Risk of Sepsis

Sepsis

Part of Infections clinical trials.

This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
78 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • A doctor placed a sepsis order-set (a special treatment plan for sepsis) for you within the last 2 days.
  • You are not already in the intensive care unit (ICU).
  • You do not have a pacemaker or similar implanted device that could interfere with electroacupuncture.
  • You are able to give consent, or a family member or legal representative can give consent for you.
  • If you are in another treatment trial, that trial’s lead doctor must say it’s okay for you to join this study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06666946Recruiting
Electroacupuncture for sepsis patients in the ICU

This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.

Wuhan, Hubei
NCT06278675Not yet recruiting
Electroacupuncture for intensive care patients with serious lung failure

This trial tests whether adding electroacupuncture (a treatment using gentle electrical pulses on thin needles) to standard care can help people with severe lung failure or sepsis recover faster. It is designed for ICU patients who are on a breathing machine.

Nanjing, Jiangsu
NCT07599644Recruiting
Sepsis Risk Study in Chinese ICU Patients

This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.

Shaoguan, Guangdong
NCT06514339Recruiting· Early Phase 1
Shenhuang granules for sepsis treatment

This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.

Hangzhou, Zhejiang
NCT07154615Recruiting
Immune system study in sepsis patients

This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.

Minneapolis, Minnesota
NCT07812012Not yet recruiting
Stem cells to treat immune problems in sepsis

This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.

Dijon

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.